How effective is Viibryd for Depression? (a real world drug study)
Summary:
Overall ratings: 3.1/5 Long term ratings: 3.5/5
This is a phase IV clinical study of how effective Viibryd (vilazodone hydrochloride) is for Depression and for what kind of people. The study is created by eHealthMe from 381 Viibryd users and is updated continuously.
What is Viibryd?
Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 11,106 Viibryd users. Check the latest studies of Viibryd.
What is Depression?
Depression is found to be associated with 3,166 drugs and 4,125 conditions by eHealthMe. Check the latest studies of Depression.
381 people are studied for taking Viibryd in Depression
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Viibryd effectiveness for Depression (number of people):
Overall:
- not at all: 19
- somewhat: 97
- moderate: 139
- high: 92
- very high: 34
Long Term:
- not at all: 0
- somewhat: 17
- moderate: 54
- high: 38
- very high: 21
Gender of people who take Viibryd for Depression *:
- female: 77.69 %
- male: 22.31 %
Age of people who take Viibryd for Depression *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 2.62 %
- 20-29: 12.86 %
- 30-39: 27.56 %
- 40-49: 24.15 %
- 50-59: 18.9 %
- 60+: 13.91 %
Who find Viibryd more effective for Depression?
Gender of people who take Viibryd for Depression *:
- female: 73.02 %
- male: 26.98 %
Age of people who take Viibryd for Depression *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 1.5899999999999999 %
- 20-29: 17.46 %
- 30-39: 26.19 %
- 40-49: 26.19 %
- 50-59: 15.08 %
- 60+: 13.49 %
* Approximation only. Some reports may have incomplete information.
Do you take Viibryd?
- You can start a phase IV clinical trial to monitor Viibryd safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Viibryd (11,106 reports)
Treatments, associated drugs and conditions:
- Depression (652,144 reports)
How the study uses the data?
The study is based on vilazodone hydrochloride (the active ingredients of Viibryd) and Viibryd (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Coumadin cause Hepatic Cirrhosis? - a second ago
- Fear Of Disease and drugs of ingredients of ciclesonide - 5 seconds ago
- Drug Ineffective and drugs of ingredients of imatinib mesylate - 7 seconds ago
- Nausea and drugs of ingredients of zoledronic acid - 8 seconds ago
- Hyperphosphataemia and drugs of ingredients of aspirin - 9 seconds ago
- Capecitabine and Acute Myeloid Leukaemia for Women aged 60+ - 16 seconds ago
- Irbesartan and Pravastatin Sodium drug interactions for women aged 50-59 - 20 seconds ago
- Could Revia cause Fatigue? - 21 seconds ago
- Could Actos cause Muscle Disorder? - 22 seconds ago
- Cytotec and Dyspnoea for Women aged 40-49 - 25 seconds ago